X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (52) 52
hematology (45) 45
index medicus (44) 44
middle aged (38) 38
male (36) 36
female (33) 33
aged (31) 31
adult (29) 29
oncology (25) 25
aged, 80 and over (16) 16
multiple myeloma - drug therapy (14) 14
therapy (13) 13
lymphoma (12) 12
bortezomib (11) 11
multiple myeloma (11) 11
mutation (11) 11
treatment outcome (11) 11
chronic lymphocytic-leukemia (10) 10
retrospective studies (10) 10
abridged index medicus (9) 9
lymphomas (9) 9
prognosis (9) 9
rituximab (9) 9
survival analysis (9) 9
antineoplastic agents - therapeutic use (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
chemotherapy (8) 8
follow-up studies (8) 8
hematology, oncology and palliative medicine (8) 8
waldenstrom macroglobulinemia (8) 8
waldenstrom macroglobulinemia - diagnosis (8) 8
waldenstrom macroglobulinemia - genetics (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
boronic acids - adverse effects (7) 7
care and treatment (7) 7
diagnosis (7) 7
disease progression (7) 7
fludarabine (7) 7
monoclonal gammopathy of undetermined significance - genetics (7) 7
multiple-myeloma (7) 7
pyrazines - adverse effects (7) 7
risk factors (7) 7
survival (7) 7
waldenstroms macroglobulinemia (7) 7
bone marrow - pathology (6) 6
cyclophosphamide - administration & dosage (6) 6
features (6) 6
leukemia (6) 6
myeloid differentiation factor 88 - genetics (6) 6
recurrence (6) 6
risk (6) 6
undetermined significance (6) 6
waldenstrom macroglobulinemia - drug therapy (6) 6
analysis (5) 5
antineoplastic agents - adverse effects (5) 5
article (5) 5
bing-neel syndrome (5) 5
boronic acids - therapeutic use (5) 5
cancer (5) 5
immunoglobulin m (5) 5
neuropathy (5) 5
patients (5) 5
progression (5) 5
pyrazines - therapeutic use (5) 5
trial (5) 5
waldenström macroglobulinemia (5) 5
biopsy (4) 4
boronic acids - administration & dosage (4) 4
central-nervous-system (4) 4
classification (4) 4
dexamethasone (4) 4
dexamethasone - administration & dosage (4) 4
disease (4) 4
disorders (4) 4
epidemiology (4) 4
follicular lymphoma (4) 4
immunochemotherapy (4) 4
macroglobulinemia (4) 4
marginal zone lymphoma (4) 4
monoclonal gammopathy (4) 4
multiple myeloma - blood (4) 4
multiple myeloma - complications (4) 4
myd88 l265p (4) 4
polymerase chain reaction (4) 4
pyrazines - administration & dosage (4) 4
refractory myeloma (4) 4
stem-cell transplantation (4) 4
transplantation (4) 4
villous lymphocytes (4) 4
waldenstrom macroglobulinemia - pathology (4) 4
waldenström macroglobulinaemia (4) 4
amyloidosis (3) 3
antibodies, monoclonal, murine-derived - administration & dosage (3) 3
biomarkers (3) 3
bone marrow (3) 3
central nervous system (3) 3
consensus panel recommendations (3) 3
cyclophosphamide (3) 3
evolution (3) 3
health aspects (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 18, pp. 1733 - 1747
Journal Article
Leukemia, ISSN 0887-6924, 2019, Volume 33, Issue 11, pp. 2654 - 2661
A staging system was developed a decade ago for patients with Waldenström’s macroglobulinemia (WM), however, since then WM treatments have changed. A revised... 
Medical prognosis | Rituximab | Risk | Serum albumin | Patients | b2-microglobulin | Macroglobulinemia
Journal Article
Blood, ISSN 0006-4971, 03/2013, Volume 121, Issue 13, pp. 2522 - 2528
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 121, Issue 11, pp. 2051 - 2058
Journal Article
American Journal of Hematology, ISSN 0361-8609, 11/2019, Volume 94, Issue 11, pp. 1193 - 1199
Lymphoplasmacytic lymphoma (LPL) is usually associated with a serum IgM paraprotein, corresponding to Waldenström's Macroglobulinemia (WM). Cases presenting... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2026 - 2026
Abstract Bakground. The association of light chain (AL) amyloidosis with lymphoplasmacytic lymphoma/Waldenström's Macroglobulinemia is well established.... 
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 2017, Volume 9, Issue 1, pp. e2017061 - e2017061
The Bing-Neel syndrome is a rare neurological complication of Waldenström’s Macroglobulinemia which results from a direct involvement of central nervous system... 
Bing-neel syndrome | Central Nervous System | Waldenström's Macroglobulinemia | Bing-Neel Syndrome | Waldenström’s Macroglobulinemia
Journal Article
Hematological Oncology, ISSN 0278-0232, 09/2017, Volume 35, Issue 3, pp. 296 - 302
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1609 - 1609
Abstract Background: The oral BTK inhibitor ibrutinib is the only approved therapy for patients with symptomatic Waldenström macroglobulinemia (WM). Bing-Neel... 
Journal Article